Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Pharmaceuticals
Pharmaceuticals - Indian - Bulk Drugs & Formln M/S
497 Cr
Low Risk
—
30.8
—
3.1
511.00
215.55
Sales CAGR
1Y
—
3Y
—
5Y
—
10Y
—
Profit CAGR
1Y
—
3Y
—
5Y
—
10Y
—
ROE
TTM
—
3Y
—
5Y
—
10Y
—
ROCE
TTM
—
3Y
—
5Y
—
10Y
—
Bearish
4
Neutral
3
Bullish
7
Bearish
36
Neutral
3
Bullish
7
Bearish
32
Neutral
0
Bullish
0
Performance
STEADY PERFORMER
Valuation
REASONABLE
Growth
STABLE
Profitability
MODERATE MARGIN
Technicals
Bearish
Risk
MODERATE RISK
Market Cap
₹ 497 Cr
P/E
—